Previous 10 | Next 10 |
--News Direct-- BioVie Inc CEO Cuong Do joined Steve Darling from Proactive to provide an update to shareholders on the company's progress in developing innovative drug therapies for advanced liver disease, as well as neurological and neurodegenerative disorders. In a letter to shareh...
Treatment with NE3107 led to >50% reductions in DNA methylation of 400 CpGs* and some in a manner that was significantly correlated to observed clinical improvements in cognition and various biomarkers. Over 3,000 significant correlations were found linking reductions in DNA methylati...
--News Direct-- BioVie Chief Medical Officer Dr. Joe Palumbo joins Natalie Stoberman from the Proactive newsroom to share how the company plans to present its research on neurodegenerative diseases at the Alzheimer’s Associate’s International Conference (AAIC) to be held in ...
(NewsDirect) BioVie Chief Medical Officer Dr. Joe Palumbo joins Natalie Stoberman from the Proactive newsroom to share how the company plans to present its research on neurodegenerative diseases at the Alzheimer’s Associate’s International Conference (AAIC) to be held in Ams...
CARSON CITY, Nev., July 10, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease...
--News Direct-- BioVie Chief Social Impact Officer Sarah Hoit joined Proactive's Natalie Stoberman to bring more awareness to Alzheimer's and Brain Awareness month. Hoit shared how the company's initiatives are trying to positively impact the families and caregivers, as well as findin...
2023-06-26 12:52:19 ET Gainers: Benitec Biopharma ( BNTC ) +76% . MoonLake Immunotherapeutics ( MLTX ) +68% . Paltalk ( PALT ) +27% . Whole Earth Brands ( FREE ) +26% . Shengfeng Development Limited ( SFWL ) +26% . Belite Bio...
2023-06-26 10:08:32 ET Gainers: MoonLake Immunotherapeutics ( MLTX ) +69% . Chemomab Therapeutics ( CMMB ) +33% . Acelyrin ( SLRN ) +22% . ORIC Pharmaceuticals ( ORIC ) +15% . Losers: Avalo Therapeutics ( AVTX ) -85% . Fi...
CARSON CITY, Nev., June 26, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease,...
2023-06-23 16:49:28 ET Summary BioVie will produce some lateral data from its phase 3 trial tomorrow. I was not overly impressed by its Alzheimer's program; the ascites program seemed more promising. The company is precariously low on cash. I will avoid for the time being. ...
News, Short Squeeze, Breakout and More Instantly...
ORLANDO, FL / ACCESSWIRE / July 5, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 6, at 7 p.m. Eastern Ti...
SUNRISE-PD to evaluate the effect of bezisterim (NE3107) on motor and non-motor symptoms in ~60 patients with Parkinson’s disease who are naïve to carbidopa/levodopa Additional presentation at congress highlighted data from earlier Phase 2a trial of bezisterim in Parkinson...
ORLANDO, FL / ACCESSWIRE / June 21, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Mobilicom Ltd. (Nasdaq:MOB) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, June 22, at 7 p.m. Eastern Time (ET). Bloomb...